Today: 29 April 2026

S&P Global stock rebounds after tariff jitters as SPGI investors eye Feb. 10 earnings

S&P Global stock rebounds after tariff jitters as SPGI investors eye Feb. 10 earnings

S&P Global shares rose 1.5% to $527.06 by early afternoon Wednesday, rebounding after a 5% drop Tuesday. The move followed market turmoil triggered by new U.S. tariffs on European goods and uncertainty over President Trump’s Greenland policy. The S&P 500 fell 2.1% Tuesday, its sharpest decline since October. Investors are now watching for S&P Global’s earnings on Feb. 10.
21 January 2026
··
Western Digital stock jumps nearly 7% as Wall Street lifts targets ahead of earnings, Innovation Day

Western Digital stock jumps nearly 7% as Wall Street lifts targets ahead of earnings, Innovation Day

Western Digital shares jumped 6.9% to $238.39 Wednesday after Citi, UBS, and Bank of America raised price targets, citing strong cloud demand and tight drive supply. The company reports quarterly earnings Jan. 29 and will host an Innovation Day Feb. 3. Seagate shares also rose 3.1%. Investors are watching for updates on pricing, margins, and capacity bookings as data storage stocks rally.
21 January 2026
···
USA Rare Earth stock slips after early jump on France-backed Lacq plant plan

USA Rare Earth stock slips after early jump on France-backed Lacq plant plan

USA Rare Earth shares fell 1.6% to $18.90 by midday Wednesday after jumping 12% earlier, following news France will back its new rare earth metals plant with tax credits. The company plans a 3,750-ton-per-year facility in Lacq, France, with government support covering up to 45% of equipment costs. Investors remain focused on funding, permits, and execution risks as the project moves forward.
21 January 2026
··
ServisFirst Bancshares stock jumps 13% as SFBS rallies on Q4 margin gains and Wall Street upgrades

ServisFirst Bancshares stock jumps 13% as SFBS rallies on Q4 margin gains and Wall Street upgrades

ServisFirst Bancshares shares surged 13% to close at $86.27 Wednesday after fourth-quarter results topped expectations. The bank reported $1.58 diluted EPS, $86.4 million net income, and a 3.38% net interest margin. Raymond James and Piper Sandler upgraded the stock, citing margin growth and loan expansion. Non-performing assets rose to 0.97% of total assets, up from 0.26% a year earlier.
21 January 2026
··
Lucid stock jumps on Rockwell Saudi factory deal — here’s what traders watch next

Lucid stock jumps on Rockwell Saudi factory deal — here’s what traders watch next

Lucid shares jumped 13% Wednesday after Rockwell Automation expanded its partnership to supply FactoryTalk MES software for Lucid’s Saudi plant. Rockwell said Lucid will use the software to manage key production areas and train local staff. Investors await Lucid’s Feb. 24 earnings for updates on cash burn and production targets. Rockwell shares rose 3%.
21 January 2026
···
Capital One stock rebounds as tariff jitters ease; COF in focus on rate-cap talk and earnings

Capital One stock rebounds as tariff jitters ease; COF in focus on rate-cap talk and earnings

Capital One shares rose 1.3% to $231.65 midday Wednesday after a pause in the recent market sell-off. The stock had dropped 4.36% Tuesday, lagging financial peers as Wall Street saw its sharpest decline in three months following new tariff threats from President Trump. Investors are watching for Capital One’s Q4 earnings after Thursday’s close, with focus on credit costs and policy risks.
21 January 2026
···
Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings

Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings

Thermo Fisher shares rose 1.6% to $628.63 by midday Wednesday, outpacing the broader market ahead of next week’s earnings release. Goldman Sachs raised its price target to $710, maintaining a “buy” rating. The NYSE notified the SEC it will delist Thermo Fisher’s 3.200% senior notes due 2026, affecting only the debt instrument. Investors await the company’s January 29 report and conference call for updates on lab demand and pharma services.
21 January 2026
··
Cisco stock price today: Why CSCO is steady after Tuesday’s slide

Cisco stock price today: Why CSCO is steady after Tuesday’s slide

Cisco shares rose 0.2% to $73.53 midday Wednesday, rebounding after a 2.45% drop in the previous session. The move followed news of a multi-year Wi‑Fi 7 contract with Georgetown University and comes ahead of Cisco’s upcoming earnings. Broader U.S. markets steadied as investors weighed Trump’s Davos remarks and tariff risks. About 6.3 million Cisco shares traded by late morning.
21 January 2026
··
Intel stock jumps nearly 10% as upgrades stack up ahead of earnings

Intel stock jumps nearly 10% as upgrades stack up ahead of earnings

Intel shares jumped about 10% by midday Wednesday after upgrades from Seaport and HSBC, pushing the stock to multi-year highs ahead of Thursday’s earnings report. Investors are focused on guidance, server-chip demand tied to AI, and foundry progress. Options markets anticipate an 8% swing after results. Morgan Stanley’s sector downgrade weighed on peers but did not halt Intel’s rally.
21 January 2026
···
Microsoft CEO Nadella warns AI could become a bubble — and lose “social permission” over energy

Microsoft CEO Nadella warns AI could become a bubble — and lose “social permission” over energy

Microsoft CEO Satya Nadella warned at Davos that AI could become a bubble if its benefits stay limited to major tech firms and wealthy countries. He tied AI growth to rising energy costs and the need for broader economic impact. Microsoft shares fell 2.3% to $443.89 after his remarks. Nadella said AI’s future depends on expanding beyond cloud giants and overcoming power constraints.
21 January 2026
·····
BlackRock’s Larry Fink floats Dublin or Detroit as WEF weighs moving Davos meeting

BlackRock’s Larry Fink floats Dublin or Detroit as WEF weighs moving Davos meeting

World Economic Forum leaders are considering moving or rotating their annual meeting away from Davos, the Financial Times reported, citing sources. BlackRock CEO Larry Fink urged the forum to hold events in cities like Dublin and Detroit. Swiss officials reiterated their support for Davos and Switzerland as central hubs. Organizers face challenges with Davos’s infrastructure and rising security costs.
21 January 2026
1 … 530 531 532 533 534 … 1,880

Stock Market Today

  • Peoples Bancorp (PEBO) Sees Share Price Momentum Amid Valuation Debate
    April 29, 2026, 9:20 AM EDT. Peoples Bancorp (PEBO) has gained investor focus following a robust share price rise, closing at $34.92. The Ohio-based regional bank, generating $424 million in annual revenue and $110 million in net income, holds a market value near $1.23 billion. Its recent returns include a 7.5% rise over one month and 15.8% year-to-date, with a 27.2% total shareholder return in one year, signaling growing momentum. Analysts place its intrinsic value around $37.17, about 6% above the current price, suggesting a modest undervaluation. Growth drivers include loan expansion, deposit growth, and strategic capital management. However, risks from credit costs and funding pressures may affect margins. Investors are advised to weigh these factors when considering PEBO amid a competitive community banking landscape.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop